![Shire plc Shire plc](/images/stories/logo/shire.gif)
"We are proud to support the education of future medical professionals," said Roger Adsett, senior vice president of Shire's gastroenterology business unit. "As a company committed to advancing gastroenterology, we hope the individuals who complete the Shire-supported fellowships will provide important contributions to bettering patient care."
Institutions receiving support from Shire in the form of charitable contributions include: Cedars-Sinai Medical Center (Los Angeles), Cleveland Clinic, Mayo Clinic (Rochester, Minn.), Mount Sinai Medical Center (New York), University of California, San Francisco, and University of Chicago Medical Center. Shire selected these Centers of Excellence based on the centers' existing fellowship programs.
"Thanks to Shire's generous support, we will be able to increase the number of practicing physicians dedicated to treating inflammatory bowel disease, for which there is a growing need," said Daniel Present, MD, clinical professor of medicine and gastroenterology, at New York's Mount Sinai School of Medicine. "Fellowships are vital in generating valuable research and improving patient care."
The institutions selected the fellowship recipients in June for fellowships that will begin July 2011. Medical students were selected for the fellowships by the individual medical institutions based on pre-existing criteria.
About Shire plc
Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company's website: www.shire.com.